Litigation Details for Kowa Company, LTD. v. Orient Pharma Co., LTD. (N.D. Ill. 2014)
✉ Email this page to a colleague
Kowa Company, LTD. v. Orient Pharma Co., LTD. (N.D. Ill. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-05-07 |
Court | District Court, N.D. Illinois | Date Terminated | 2014-11-26 |
Cause | 35:271 Patent Infringement | Assigned To | Matthew F. Kennelly |
Jury Demand | None | Referred To | |
Parties | KOWA COMPANY, LTD. | ||
Patents | 6,465,477; 8,557,993 | ||
Attorneys | Katherine E Rohlf | ||
Firms | Locke Lord LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Kowa Company, LTD. v. Orient Pharma Co., LTD.
Details for Kowa Company, LTD. v. Orient Pharma Co., LTD. (N.D. Ill. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2014-05-07 | 1 | 14. United States Patent No. 6,465,477 (“the ‘477 patent”), entitled “Stable Pharmaceutical… The Patents in Suit 12. United States Patent No. 5,856,336 (“the ‘336 patent”), entitled…. This is an action for patent infringement arising under the patent laws of the United States, …assignment of the ‘336 patent, which expires on December 25, 2020 pursuant to a patent-term extension. KCL…licensee for the ‘336 patent and KPA holds a license from KCL for the ‘336 patent. | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |